Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-000062

CFO acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shin Barry CFO 2026-01-02 Grant or award +125,000 $5.17 $646,250 525,000 D
Derivatives
Shin Barry CFO 2026-01-02 Grant or award · Stock Option (Right to Buy) +670,000 670,000 D
Loading xslF345X05/ownership.xml…